Charles Schwab’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.18M | Buy |
458,248
+12,070
| +3% | +$110K | ﹤0.01% | 2403 |
|
|
2025
Q1 | $3.55M | Sell |
446,178
-16,131
| -3% | -$128K | ﹤0.01% | 2416 |
|
|
2024
Q4 | $2.51M | Buy |
462,309
+10,116
| +2% | +$54.9K | ﹤0.01% | 2607 |
|
|
2024
Q3 | $3.26M | Buy |
452,193
+43,617
| +11% | +$315K | ﹤0.01% | 2559 |
|
|
2024
Q2 | $4.44M | Buy |
408,576
+21,437
| +6% | +$233K | ﹤0.01% | 2411 |
|
|
2024
Q1 | $7.25M | Sell |
387,139
-26,766
| -6% | -$502K | ﹤0.01% | 2148 |
|
|
2023
Q4 | $8.97M | Buy |
413,905
+4,918
| +1% | +$107K | ﹤0.01% | 2044 |
|
|
2023
Q3 | $8.42M | Buy |
408,987
+17,819
| +5% | +$367K | ﹤0.01% | 1998 |
|
|
2023
Q2 | $18.4M | Buy |
391,168
+5,751
| +1% | +$270K | 0.01% | 1560 |
|
|
2023
Q1 | $16.2M | Sell |
385,417
-159
| -0% | -$6.67K | ﹤0.01% | 1623 |
|
|
2022
Q4 | $14.7M | Buy |
385,576
+8,161
| +2% | +$311K | ﹤0.01% | 1638 |
|
|
2022
Q3 | $14.8M | Buy |
377,415
+7,765
| +2% | +$304K | 0.01% | 1598 |
|
|
2022
Q2 | $11.9M | Buy |
369,650
+101,705
| +38% | +$3.29M | ﹤0.01% | 1740 |
|
|
2022
Q1 | $8.87M | Buy |
267,945
+8,911
| +3% | +$295K | ﹤0.01% | 2019 |
|
|
2021
Q4 | $11M | Buy |
259,034
+3,101
| +1% | +$132K | ﹤0.01% | 1952 |
|
|
2021
Q3 | $11.3M | Sell |
255,933
-17,422
| -6% | -$772K | ﹤0.01% | 1931 |
|
|
2021
Q2 | $15.5M | Buy |
273,355
+7,283
| +3% | +$414K | 0.01% | 1758 |
|
|
2021
Q1 | $19.9M | Buy |
266,072
+6,723
| +3% | +$503K | 0.01% | 1534 |
|
|
2020
Q4 | $22.4M | Buy |
259,349
+3,460
| +1% | +$299K | 0.01% | 1319 |
|
|
2020
Q3 | $15.6M | Buy |
255,889
+2,973
| +1% | +$182K | 0.01% | 1376 |
|
|
2020
Q2 | $10.5M | Buy |
252,916
+6,982
| +3% | +$290K | 0.01% | 1616 |
|
|
2020
Q1 | $7.06M | Buy |
245,934
+4,604
| +2% | +$132K | ﹤0.01% | 1647 |
|
|
2019
Q4 | $17.4M | Buy |
241,330
+4,026
| +2% | +$291K | 0.01% | 1306 |
|
|
2019
Q3 | $33.3M | Buy |
237,304
+12,285
| +5% | +$1.72M | 0.02% | 831 |
|
|
2019
Q2 | $41.2M | Buy |
225,019
+12,134
| +6% | +$2.22M | 0.03% | 671 |
|
|
2019
Q1 | $33.9M | Buy |
212,885
+26,278
| +14% | +$4.18M | 0.02% | 776 |
|
|
2018
Q4 | $17.9M | Buy |
186,607
+9,056
| +5% | +$868K | 0.01% | 1062 |
|
|
2018
Q3 | $25.1M | Buy |
177,551
+6,042
| +4% | +$853K | 0.02% | 1000 |
|
|
2018
Q2 | $26.8M | Sell |
171,509
-62,436
| -27% | -$9.77M | 0.02% | 867 |
|
|
2018
Q1 | $37.7M | Buy |
233,945
+44,715
| +24% | +$7.2M | 0.03% | 613 |
|
|
2017
Q4 | $31.2M | Buy |
189,230
+38,204
| +25% | +$6.29M | 0.02% | 680 |
|
|
2017
Q3 | $9.41M | Buy |
151,026
+12,847
| +9% | +$800K | 0.01% | 1481 |
|
|
2017
Q2 | $11M | Buy |
138,179
+6,739
| +5% | +$537K | 0.01% | 1281 |
|
|
2017
Q1 | $9.34M | Buy |
131,440
+1,593
| +1% | +$113K | 0.01% | 1358 |
|
|
2016
Q4 | $6.63M | Buy |
129,847
+23,460
| +22% | +$1.2M | 0.01% | 1551 |
|
|
2016
Q3 | $4.9M | Buy |
106,387
+35,346
| +50% | +$1.63M | 0.01% | 1662 |
|
|
2016
Q2 | $2.14M | Buy |
71,041
+16,662
| +31% | +$502K | ﹤0.01% | 2041 |
|
|
2016
Q1 | $1.74M | Buy |
54,379
+14,449
| +36% | +$463K | ﹤0.01% | 2120 |
|
|
2015
Q4 | $2.33M | Buy |
39,930
+3,453
| +9% | +$201K | ﹤0.01% | 2004 |
|
|
2015
Q3 | $1.54M | Buy |
36,477
+16,582
| +83% | +$702K | ﹤0.01% | 2208 |
|
|
2015
Q2 | $1.45M | Buy |
19,895
+11,895
| +149% | +$869K | ﹤0.01% | 2245 |
|
|
2015
Q1 | $402K | Hold |
8,000
| – | – | ﹤0.01% | 2713 |
|
|
2014
Q4 | $293K | Buy |
+8,000
| New | +$293K | ﹤0.01% | 2849 |
|